Evidence map›Paper›PMID 39975855›Full record

ArticleMethodsX2025

Prediction of the remaining useful life of a milling machine using machine learning.

Abbas Al-Refaie, Majd Al-Atrash, Natalija Lepkova

Abstract read
In one paragraph

Article in MethodsX, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Abbas Al-RefaieDepartment of Industrial Engineering, University of Jordan, Amman, 11942, Jordan.
Majd Al-AtrashReveived Master's degree in industrial Engineering, Department of Industrial Engineering, University of Jordan, Amman, 11942, Jordan.
Natalija LepkovaDepartment of Construction Management and Real Estate, Vilnius Gediminas Technical University, Vilnius, Lithuania.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The cutting tool is a key component of the milling machine that decides productivity. Hence, an adequate predictive maintenance (PdM) strategy for the cutting tools becomes necessary. This research seeks to develop a smart maintenance web application that utilizes Machine Learning (ML) supervised models to predict the Remaining Useful Life (RUL) for milling operations. The ML models were developed using a four-stage process including data pre-processing, training, evaluation, and deployment. Several ML algorithms were applied and the results were evaluated using five measures involving Accuracy, Mean Absolute Error (MAE), Mean Squared Error (MSE), R-squared, and R-squared adjusted. It was found that the Multi-Layer Perceptron Regressor provided the largest accuracies, adjusted R-squared, MAE, and MSE of 99 %, 0.99, 3.7, and 23.13, respectively. A web application for maintenance was finally developed with several ML algorithms at the evaluation stage. Maintenance engineers can utilize the developed smart web application to monitor the machine's health state and predict failure occurrence. In conclusion, the developed web application assists engineers in developing reliable predictions of maintenance activities, which may save costly production and maintenance losses.•A Web application based on machine learning techniques was developed for RUL predictions for the milling cutting tool.•A comparison between the prediction results from various machine learning techniques was conducted.•The web application is found to be valuable for maintenance prediction and planning.

Indexed as

Machine learningMachine LearningMilling machineMulti-Layer perceptron regressorPredictive maintenanceRemaining useful life

Identifiers

PMID39975855
PMCPMC11836486

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.